跳至主要内容
临床试验/CTRI/2024/03/064215
CTRI/2024/03/064215尚未招募4 期

A Prospective, Randomized And Open Label Study To Compare The Efficacy And Safety Of Metformin Versus Metformin And Fluoxetine In Patients Of Type 2 Diabetes Mellitus With Mild Depression - Nil

ot Available0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Diagnosed cases of T2DM
  • HbA1c = 6.5%.
  • FPG = 126 mg/dl (7.0 mmol/l) after 8 hours of Fasting.
  • 2-hour plasma glucose = 200 mg/dl (11.1 mmol/l) during an OGTT.
  • In a patient with classic symptoms of hyperglycemia, a random
  • plasma glucose =200 mg/dl (11.1 mmol/l).
  • Diagnosed cases of concomitant Mild Depression according to ICD-11.
  • Patients between the ages of 18-65 years of both sexes.
  • Patients willing to join the study after giving the informed consent

排除标准

  • Patients with Type 1 DM, Diabetes Insipidus, Acromegaly, Cushing’s Syndrome, Thyrotoxicosis, Anaemia in Pregnancy, and Haemoglobinopathies.
  • Patients with any Organic cause of Depression.
  • Any other Psychiatric comorbidities.
  • Any other comorbidities like Cardiovascular, Renal and Hepatic diseases.
  • Special Physiological conditions like Pregnancy and Lactation.
  • Patients using drugs that can induce Diabetes: Corticosteroids, Thiazides, Phenytoin, Beta Blockers, Antipsychotics, Statins.
  • Patients using drugs that can cause Depression: Corticosteroids; Benzodiazepines – Alprazolam, Clonazepam, Chlordiazepoxide, Diazepam,
  • Flurazepam, Lorazepam, Triazolam; Anticonvulsants – Ethosuximide; Beta Adrenergic Blockers – Metoprolol, Atenolol, Carvedilol; Interferon a; Opiods – Codeine, Meperidine, Morphine, Oxycodone; Statins – Atorvastatin, Fluvastatin, Pravastatin, Simvastatin.
  • Patients using drugs that may interact with Metformin - Acetazolamide, Methazolamide, Dichlorphenamide, Topiramate, Zonisamide,
  • Patients using drugs that may interact with Fluoxetine - Antidepressants - Monoamine Oxidase Inhibitors (MAOI), Selective Serotonin Reuptake
  • Inhibitors (SSRIs), Tricyclic Antidepressants (TCAs); Pimozide; Thioridazone; Tamoxifen; Calcium Channel Blockers; Cyproheptadine;
  • Amino Acids L-Dopa and L-Tryptophan; Anorexiants - Fenfluramine, Anticonvulsants – Carbamazapine, Phenytoin; and Anxiolytics – Alprazolam,
  • Buspirone, Diazepam.

研究者

发起方
ot Available

相似试验